Is a complete PALI research report available?

No complete published report is available for Palisade Bio, Inc. (PALI) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Palisade Bio, Inc. (PALI)

NASDAQ: PALI · USD

$1.20

+0.00 (0.0%)· Recorded snapshot

Market cap	209.1M
Revenue (ttm)	500K
Net income (ttm)	-31.9M
EPS (ttm)	-$0.20
Shares out	174.3M
Volume	14,821,969
Beta	1.62

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 500K
Net income (ttm): -31.9M
EPS (ttm): -$0.20
Market cap: 209.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Metric	Value
Amount currency	USD
CIK code	0001357459
Company name	Palisade Bio, Inc.
Country	United States
Country code	US
CUSIP number	696389402
Earnings date	2026-11-09
Earnings time	amc
Employees	14
Employees change	6
Employees growth	75%
Enterprise value	$84M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1996
In index	RUSSELL2000
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US6963894026
Last 10-K release date	2026-03-20
Last earnings date	2026-08-10
Last refreshed	2026-10-28
Last stock split date	2024-04-08
Last stock split type	Reverse
Market cap	$209.1M
Market cap category	Micro-Cap
Next earnings date	2026-11-09
Options	No
Price	$1.20
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	PALI
U.S. state	Colorado
Website	https://www.palisadebio.com

Metric

Value

Amount currency

USD

CIK code

0001357459

Company name

Palisade Bio, Inc.

Country

United States

Country code

CUSIP number

696389402

Earnings date

2026-11-09

Earnings time

amc

Employees

Employees change

Employees growth

75%

Enterprise value

$84M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1996

In index

RUSSELL2000

Industry

Biotechnology

Is primary listing

Yes

Is SPAC

ISIN number

US6963894026

Last 10-K release date

2026-03-20

Last earnings date

2026-08-10

Last refreshed

2026-10-28

Last stock split date

2024-04-08

Last stock split type

Reverse

Market cap

$209.1M

Market cap category

Micro-Cap

Next earnings date

2026-11-09

Options

Price

$1.20

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

PALI

U.S. state

Colorado

Website

https://www.palisadebio.com

Metric	Value
Earnings yield	-16.79%
EV/Sales	150.48x
FCF / EV yield	-24.18%
FCF yield	-9.08%
P/B ratio	1.71x
P/S ratio	400.82x
Price / tangible book value	1.65x
Sector forward P/E	23.53x
Sector P/E	51.01x

Metric

Value

Earnings yield

-16.79%

EV/Sales

150.48x

FCF / EV yield

-24.18%

FCF yield

-9.08%

P/B ratio

1.71x

P/S ratio

400.82x

Price / tangible book value

1.65x

Sector forward P/E

23.53x

Sector P/E

51.01x

Metric	Value
Gross margin	100%
Operating margin	-7,069.8%
Pretax margin	-6,388.2%
Profit per employee	$-2.3M
Revenue per employee	$35,714
ROA	-32.98%
ROA (5Y)	-61.21%
ROCE	-28.96%
ROE	-51.37%
ROE (5Y)	-4,087.44%
ROIC	-35.43%
SBC / revenue	2,579.8%

Metric

Value

Gross margin

100%

Operating margin

-7,069.8%

Pretax margin

-6,388.2%

Profit per employee

$-2.3M

Revenue per employee

$35,714

ROA

-32.98%

ROA (5Y)

-61.21%

ROCE

-28.96%

ROE

-51.37%

ROE (5Y)

-4,087.44%

ROIC

-35.43%

SBC / revenue

2,579.8%

Metric	Value
EPS growth quarters	10
EPS growth years	12
Gross profit growth 3Y	25.99%
Net income growth years	0
Revenue growth 3Y	25.99%
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Gross profit growth 3Y

25.99%

Net income growth years

Revenue growth 3Y

25.99%

Revenue growth years

Metric	Value
Depreciation and amortization	$2,500
EBIT	$-35.3M
EBITDA	$-35.3M
EPS	$-0.20
FCF per share	$-0.10
Financing cash flow	$138M
Free cash flow	$-18.2M
Free cash flow minus SBC	$-31.1M
Gross profit	$500,000
Net borrowing	$-311,000
Net cash flow	$119.8M
Net income	$-31.9M
Operating cash flow minus SBC	$-31.1M
Operating income	$-35.3M
Revenue	$500,000
Stock-based compensation	$12.9M

Metric

Value

Depreciation and amortization

$2,500

EBIT

$-35.3M

EBITDA

$-35.3M

EPS

$-0.20

FCF per share

$-0.10

Financing cash flow

$138M

Free cash flow

$-18.2M

Free cash flow minus SBC

$-31.1M

Gross profit

$500,000

Net borrowing

$-311,000

Net cash flow

$119.8M

Net income

$-31.9M

Operating cash flow minus SBC

$-31.1M

Operating income

$-35.3M

Revenue

$500,000

Stock-based compensation

$12.9M

Metric	Value
Altman Z-Score	21.8
Book value per share	$0.70
Debt / equity	0
Interest coverage	-4,418.63
Long-term assets	$55,000
Long-term liabilities	$321,000
Net cash (debt)	$125.2M
Net cash / market cap	62.46%
Net cash growth	2,358.69%
Net debt / equity	-1.03
Piotroski F-Score	2
Shareholders' equity	$121.7M
Tangible book value	$121.7M
Tangible book value per share	$0.70
Total assets	$127.3M
Total cash	$125.2M
Total debt	$0
Total liabilities	$5.6M
WACC	13.16%

Metric

Value

Altman Z-Score

21.8

Book value per share

$0.70

Debt / equity

Interest coverage

-4,418.63

Long-term assets

$55,000

Long-term liabilities

$321,000

Net cash (debt)

$125.2M

Net cash / market cap

62.46%

Net cash growth

2,358.69%

Net debt / equity

-1.03

Piotroski F-Score

Shareholders' equity

$121.7M

Tangible book value

$121.7M

Tangible book value per share

$0.70

Total assets

$127.3M

Total cash

$125.2M

Total debt

Total liabilities

$5.6M

WACC

13.16%

Metric	Value
Asset turnover	0.01
Current assets	$127.3M
Current liabilities	$5.2M
Current ratio	24.26
Net working capital	$-3.2M
Quick ratio	23.96
Working capital	$122M
Working capital turnover	0.01

Metric

Value

Asset turnover

0.01

Current assets

$127.3M

Current liabilities

$5.2M

Current ratio

24.26

Net working capital

$-3.2M

Quick ratio

23.96

Working capital

$122M

Working capital turnover

0.01

Metric	Value
Buyback yield / dilution	-4,683.09%
Dividend yield	0%
Shareholder yield	-4,683.09%

Metric

Value

Buyback yield / dilution

-4,683.09%

Dividend yield

Shareholder yield

-4,683.09%

Metric	Value
150-day SMA	$1.88
1D price change	0%
1M price change	-18.62%
1M total return	-18.62%
1W price change	-17.48%
1W total return	-17.48%
1Y price change	-28.92%
1Y return CAGR	-28.93%
1Y total return	-28.92%
20-day SMA	$1.41
200-day SMA	$1.86
3M price change	-41.87%
3M total return	-41.87%
3Y price change	-85.46%
3Y return CAGR	-47.41%
3Y total return	-85.46%
50-day SMA	$1.69
50-day SMA vs 200-day SMA	50under200
52-week high	$2.86
52-week high date	2026-04-22
52-week low	$1.10
52-week low date	2026-10-28
5Y price change	-99.94%
5Y return CAGR	-77.46%
5Y total return	-99.94%
6M price change	-39.8%
6M total return	-39.8%
All-time high	$8,182.50
All-time high date	2021-04-28
All-time low	$0.53
All-time low date	2025-09-11
Average true range (ATR)	$0.11
Average volume	2.8M
Beta (1Y)	1.27
Beta (2Y)	-0.06
Beta (5Y)	1.62
Change from 52-week high	-57.97%
Change from 52-week low	9.09%
Change from all-time high	-99.99%
Change from all-time low	122.64%
Change from open	0%
Day's gap	0%
Dollar volume	$17.8M
High price	$1.21
Low price	$1.12
Monthly RSI	7.77
Open price	$1.20
Position in 52-week range	94.44%
Premarket change	2.16%
Premarket close	$1.20
Premarket price	$1.23
Premarket volume	10.5K
Previous close	$1.20
Price vs 150-day SMA	-37.37%
Price vs 20-day SMA	-16.43%
Price vs 200-day SMA	-36.49%
Price vs 50-day SMA	-30.22%
Relative volume	5.28
RSI	31.19
Sharpe ratio	0.04
Sharpe ratio (3Y)	-0.05
Sharpe ratio (5Y)	-0.4
Sortino ratio	0.13
Sortino ratio (3Y)	-0.03
Sortino ratio (5Y)	-0.65
Volume	14.8M
Weekly RSI	34.62
YTD price change	-49.79%
YTD total return	-49.79%

Metric

Value

150-day SMA

$1.88

1D price change

1M price change

-18.62%

1M total return

-18.62%

1W price change

-17.48%

1W total return

-17.48%

1Y price change

-28.92%

1Y return CAGR

-28.93%

1Y total return

-28.92%

20-day SMA

$1.41

200-day SMA

$1.86

3M price change

-41.87%

3M total return

-41.87%

3Y price change

-85.46%

3Y return CAGR

-47.41%

3Y total return

-85.46%

50-day SMA

$1.69

50-day SMA vs 200-day SMA

50under200

52-week high

$2.86

52-week high date

2026-04-22

52-week low

$1.10

52-week low date

2026-10-28

5Y price change

-99.94%

5Y return CAGR

-77.46%

5Y total return

-99.94%

6M price change

-39.8%

6M total return

-39.8%

All-time high

$8,182.50

All-time high date

2021-04-28

All-time low

$0.53

All-time low date

2025-09-11

Average true range (ATR)

$0.11

Average volume

2.8M

Beta (1Y)

1.27

Beta (2Y)

-0.06

Beta (5Y)

1.62

Change from 52-week high

-57.97%

Change from 52-week low

9.09%

Change from all-time high

-99.99%

Change from all-time low

122.64%

Change from open

Day's gap

Dollar volume

$17.8M

High price

$1.21

Low price

$1.12

Monthly RSI

7.77

Open price

$1.20

Position in 52-week range

94.44%

Premarket change

2.16%

Premarket close

$1.20

Premarket price

$1.23

Premarket volume

10.5K

Previous close

$1.20

Price vs 150-day SMA

-37.37%

Price vs 20-day SMA

-16.43%

Price vs 200-day SMA

-36.49%

Price vs 50-day SMA

-30.22%

Relative volume

5.28

RSI

31.19

Sharpe ratio

0.04

Sharpe ratio (3Y)

-0.05

Sharpe ratio (5Y)

-0.4

Sortino ratio

0.13

Sortino ratio (3Y)

-0.03

Sortino ratio (5Y)

-0.65

Volume

14.8M

Weekly RSI

34.62

YTD price change

-49.79%

YTD total return

-49.79%

Metric	Value
Float	135.4M
Float percentage	77.71%
Shares change (QoQ)	0.82%
Shares change (YoY)	4,683.09%
Shares held by insiders	2.3%
Shares held by institutions	80.95%
Shares outstanding	174.3M
Short % of float	22.9%
Short % of shares	17.8%
Short ratio	8.5 days

Metric

Value

Float

135.4M

Float percentage

77.71%

Shares change (QoQ)

0.82%

Shares change (YoY)

4,683.09%

Shares held by insiders

2.3%

Shares held by institutions

80.95%

Shares outstanding

174.3M

Short % of float

22.9%

Short % of shares

17.8%

Short ratio

8.5 days

Palisade Bio, Inc. (PALI)

Price

Financial snapshot

Fair-value bridge

Latest news · PALI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PALI indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on PALI

Frequently asked questions